CTN: Northern New England Node

CTN：新英格兰北部节点

• 批准号: 7498062
• 负责人: Roger D. Weiss
• 金额: $ 40万
• 依托单位: MCLEAN HOSPITAL
• 依托单位国家: 美国
• 财政年份: 2002
• 资助国家: 美国
• 起止时间: 2002-09-30 至 2010-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7498062
• 关键词: AIDS clinical trial group; AIDS prevention; AIDS/HIV problem; Abstinence; Abuse Reporting; Academic Medical Centers; Academic Training; Academy; Accounting; Accreditation; Acquired Immunodeficiency Syndrome; Acute; Address; Adherence; Administrator; Admission activity; Adolescence; Adolescent; Adolescent Development; Adolescent Psychiatry; Adopted; Adoption; Adult; Adverse effects; Adverse event; Advisory Committees; Advocate; Affect; African American; Age; Agreement; Alaska Native; Alcohol consumption; Alcohol dependence; Alcohol or Other Drugs use; Alcoholism; Alcohols; All Sites; Ambulatory Care Facilities; American; American Indians; American Psychological Association; Anti-Retroviral Agents; Anxiety Disorders; Appendix; Applications Grants; Applied Research; Appointment; Archives; Area; Arizona; Armenia; Arts; Asians; Attention; Attention deficit hyperactivity disorder; Authorship; Award; Awareness; Back; Baseline Surveys; Beds; Behavior; Behavior Therapy; Behavioral; Behavioral Medicine; Behavioral Sciences; Belief; Benefits and Risks; Benzodiazepines; Binding Sites; Biological; Biological Assay; Biometry; Bipolar Disorder; Blood; Book Chapters; Books; Boston; Brain imaging; Budgets; Buprenorphine; Businesses; CAB protocol; CD4 Lymphocyte Count; Calibration; California; Cardiovascular system; Caring; Case Management; Case Manager; Case Mixes; Case Report Form; Categories; Caucasians; Caucasoid Race; Censuses; Centers for Disease Control and Prevention (U.S.); Certificate of Confidentiality; Certification; Cervical; Chairperson; Characteristics; Charge; Child; Child Abuse; Child Psychiatry; Childhood; China; Chronic Disease; Chronology; Cigarette; Cigarette Smoker; Cities; Classification; Client; Client satisfaction; Clinic; Clinic Visits; Clinical; Clinical Practice Guideline; Clinical Psychology; Clinical Research; Clinical Services; Clinical Treatment; Clinical Trials; Clinical Trials Data Monitoring Committees; Clinical Trials Design; Clinical Trials Network; Clinical effectiveness; Cocaine; Code; Cognitive; Cognitive Therapy; Collaborations; Collection; Color; Combination Drug Therapy; Committee Members; Communication; Communication Research; Communities; Community Health Centers; Community Healthcare; Community Surveys; Comorbidity; Competence; Complement; Complex; Computer software; Condition; Conduct Clinical Trials; Confidentiality; Conflict (Psychology); Confusion; Consensus; Consent; Consent Forms; Consult; Consultations; Continuing Education; Continuity of Patient Care; Contracts; Control Groups; Counseling; Country; Couples Therapy; Criminal Justice; Cues; DSM-IV; Dace; Daily; Data; Data Aggregation; Data Analyses; Data Collection; Data Quality; Data Reporting; Databases; Day Care; Decision Making; Delaware; Dependence; Depressed mood; Detection; Developed Countries; Developing Countries; Development; Diabetes Mellitus; Diagnosis; Diagnostic; Diffusion; Diffusion of Innovation; Direct Costs; Discipline; Disease; Distance Education; Doctor of Medicine; Doctor of Philosophy; Documentation; Domestic Violence; Dose; Dropout; Drops; Drug Addiction; Drug Administration Routes; Drug Courts; Drug Evaluation; Drug Metabolic Detoxication; Drug abuse; Drug resistance; Drug usage; Drug user; Early identification; Eating Disorders; Economic Conditions; Economics; Education; Educational Activities; Educational Assessment; Educational Curriculum; Educational Intervention; Educational process of instructing; Educational workshop; Effectiveness; Effectiveness of Interventions; Electronic Mail; Electronics; Elements; Eligibility Determination; Employee; Employee Strikes; End Point; Enrollment; Ensure; Environment; Equation; Equilibrium; Equipment; Ethics; Ethnic Origin; Evaluation; Event; Evidence based practice; Evidence based treatment; Exclusion Criteria; Exercise; Expenditure; Face; Family; Family Physicians; Family psychotherapy; Fatigue; Feasibility Studies; Feedback; Feeling; Fees; Fellowship; Female; Fever; Follow-Up Studies; Fostering; Foundations; Frustration; Funding; Funding Agency; Future; Gender; Gender Issues; General Hospitals; General Population; Genie; Geography; Gifts; Goals; Government Agencies; Grant; Graph; Group Therapy; Guided imagery; Guidelines; HIV; HIV Infections; HIV Seropositivity; HIV prevention trials network; Halfway Houses; Hand; Happiness; Headache; Health; Health Alliance; Health Insurance Portability and Accountability Act; Health Personnel; Health Professional; Health Services; Health Services Accessibility; Health Services Research; Health Status; Health behavior change; Healthcare; Healthcare Systems; Hepatitis C; Hepatitis C virus; High Risk Woman; Highly Active Antiretroviral Therapy; Hispanics; Home environment; Home visitation; Homelessness; Hospitals; Hour; House Call; Human Resources; Human immunodeficiency virus test; Hybrids; Illicit Drugs; Impairment; Incentives; Independent Scientist Award; India; Individual; Industry; Infant; Infection; Information Systems; Informed Consent; Injecting drug user; Injection of therapeutic agent; Inpatients; Institute of Medicine (U.S.); Institutes; Institution; Instruction; Insurance; Intake; Intention; Interest Group; International; International Statistical Classification of Diseases and Related Health Problems, Tenth Revision (ICD-10); Intervention; Intervention Studies; Interview; Investigation; Journals; Kenya; Knowledge; Laboratories; Latina; Latino; Laws; Lead; Leadership; Learning; Lebanon; Left; Legal; Length; Length of Stay; Letters; Licensing; Life; Light; Linguistics; Link; Literature; Living Wills; Location; Logistic Regressions; Longevity; Mails; Maine; Maintenance; Managed Care; Manic; Manuals; Manuscripts; Marijuana; Massachusetts; Master of Public Health; Measurement; Measures; Mediating; Mediator of activation protein; Medical; Medical center; Medicare; Medicare/Medicaid; Medicine; Mental Depression; Mental Health; Mental Health Services; Mental disorders; Mentors; Meta-Analysis; Methadone; Methodology; Methods; Methylphenidate; Microprocessor; Mid-Career Clinical Scientist Award (K24); Mind; Minority; Minority Groups; Mission; Modality; Modeling; Modification; Monitor; Mood Disorders; Morale; Mothers; Multi-Institutional Clinical Trial; Mutation; Myanmar; Naloxone; Names; National Institute of Drug Abuse; National Institute of Mental Health; National Institute on Alcohol Abuse and Alcoholism; National Research Service Awards; Nature; Nausea; Needles; Neurology; New England; New Hampshire; Newsletter; Newspapers; Nicotine Dependence; None or Not Applicable; Numbers; Nurses; Nursing Homes; Occupations; Office of Administrative Management; Online Systems; Operative Surgical Procedures; Opiate Addiction; Opioid; Opioid Analgesics; Organizational Change; Organizational Models; Other Resources; Outcome; Outcome Assessment; Outcome Measure; Outcome Study; Outpatients; Pacific Island Americans; Pain; Pain management; Paper; Participant; Patient Education; Patient Monitoring; Patient Self-Report; Patient currently pregnant; Patients; Pattern; Pediatric Hospitals; Peer Review; Performance; Personal Satisfaction; Persons; Pharmaceutical Preparations; Pharmacotherapy; Phase; Phase III Clinical Trials; Phase Transition; Physician Executives; Physicians; Pilot Projects; Placebos; Plasma; Play; Pliability; Policies; Population; Population Programs; Positioning Attribute; Post-Traumatic Stress Disorders; Postdoctoral Fellow; Postpartum Women; Practice Guidelines; Pregnant Women; Preparation; Prevalence; Prevention; Prevention education; Prevention program; Principal Investigator; Privacy; Problem Solving; Procedures; Process; Productivity; Professional counselor; Program Description; Progress Reports; Protocols documentation; Provider; Psyche structure; Psychiatrist; Psychiatry; Psychologist; Psychology; Psychopharmacology; Psychostimulant dependence; Psychotherapy; Psychotic Disorders; Public Health; Public Policy; Publications; Publishing; Purpose; Qualifying; Quality Control; Quality of Care; Quality of life; Questionnaires; RNA; Race; Randomized; Randomized Controlled Clinical Trials; Randomized Controlled Trials; Range; Rate; Readiness; Reading; Recommendation; Recording of previous events; Records; Recovery; Recruitment Activity; Red Cross; Registered nurse; Regulation; Regulatory Affairs; Rehabilitation therapy; Relapse; Relative (related person); Report (document); Reporting; Research; Research Activity; Research Design; Research Ethics; Research Ethics Committees; Research Infrastructure; Research Institute; Research Methodology; Research Personnel; Research Project Grants; Research Training; Residencies; Residential Treatment; Resistance; Resolution; Resources; Rest; Review Committee; Review Literature; Rhode Island; Risk; Risk Behaviors; Risk Reduction; Rivers; Role; Role playing therapy; Route; Running; Rural; Russia; Safe Sex; Safety; Sample Size; Sampling; Schedule; Schizophrenia; Science; Score; Screening procedure; Secure; Self Efficacy; Self Medication; Seminal fluid; Series; Serious Adverse Event; Services; Severities; Sex Behavior; Sex Characteristics; Sexually Transmitted Diseases; Shapes; Shipping; Ships; Side; Site; Sleep disturbances; Smoke; Smoker; Smoking; Social Functioning; Social Work; Social Workers; Societies; Solid; Solutions; Source; Specific qualifier value; Staff Development; Staging; Standards of Weights and Measures; Statistical Data Interpretation; Stratification; Stress; Structure; Subgroup; Substance Abuse, Other; Substance Addiction; Substance Use Disorder; Substance abuse problem; Sum; Summary Reports; Supervision; Support Groups; Support of Research; Surveys; Survivors; Symptoms; System; Target Populations; Techniques; Technology Transfer; Telephone; Testing; Textbooks; Therapeutic; Therapeutic community technique; Thinking; Time; TimeLine; Tobacco; Toxicology; Training; Training Activity; Training Programs; Training and Education; Translating; Transportation; Trauma; Travel; Treatment Effectiveness; Treatment Efficacy; Treatment Protocols; Treatment Step; Treatment outcome; Triage; Tube; USA Georgia; Underrepresented Minority; United Nations; United States National Institutes of Health; United States Substance Abuse and Mental Health Services Administration; Universities; Update; Upper arm; Urine; Validation; Vermont; Videotape; Viral; Viral Load result; Viral load measurement; Virus; Virus Diseases; Vision; Visit; Visual Analogue Pain Scale; Vulnerable Populations; Week; Western Asia Georgia; Withdrawal; Woman; Wood material; Work; Workplace; World Health Organization; Writing; Youth; acamprosate; addiction; adolescent smoking; aminoglutethimide/danazol/hydrocortisone/tamoxifen; antiretroviral therapy; authority; base; behavioral health; career; chronic pain; cigarette smoking; clinical research site; clinically relevant; college; comparison group; computerized data processing; concept; contingency management; coping; cost; cost effective; cost effectiveness; cytarabine/daunorubicin/thioguanine; data integrity; data management; day; demographics; depressive symptoms; design; desire; disorder later incidence prevention; dissemination research; document outlines; dual diagnosis; early /brief intervention /therapy; editorial; effectiveness clinical trial; effectiveness research; ethnic minority population; expectation; experience; falls; follow-up; group counseling; health care service utilization; health related quality of life; hospital bed; human subject; implementation research; implementation trial; improved; inclusion criteria; indexing; innovation; instrument; interest; intervention program; juvenile delinquent; lectures; male; medical schools; medical specialties; medication compliance; member; men; motivational enhancement therapy; multidisciplinary; named group; neglect; neuropsychological; news; nicotine abuse; nicotine patch; novel strategies; offender; organizational structure; outreach; parity; patient oriented research; pediatrician; peer; performance site; pill; preference; prescription document; prescription procedure; prevent; probation; problem solving therapy; professor; programs; prospective; protocol development; psychoeducation; psychologic; psychological distress; psychopharmacologic; psychosocial; public policy on tobacco; quality assurance; racial and ethnic; racial difference; rehearsal; research and development; research study; research to practice; resilience; response; retinal rods; satisfaction; self help; service utilization; severe mental illness; sex; skills; smoking cessation; social; special interest group; statistics; study characteristics; substance abuser; success; symposium; therapy adherence; therapy design; therapy development; tool; topiramate; training project; transitional housing; transmission process; treatment center; treatment duration; treatment effect; treatment program; treatment site; treatment trial; trial comparing; volunteer; willingness; young adult

This is a proposal for renewal of "Clinical Trials Network (CTN): Harvard University Northern New England Node," submitted in response to RFA-DA-07-001 "Announcement of a Limited Competition of the National Drug Abuse Treatment Clinical Trials Network (U10)." The Northern New England Node (NNEN) brings together research expertise, sophisticated community treatment programs (CTPs), and a wide variety of patients being treated in diverse settings and multiple levels of care. The Node is characterized by a partnership between academic researchers and community-based treatment providers throughout 5 New England states to design and implement addiction treatment studies in community-based treatment programs. The NNEN has demonstrated outstanding progress since entering the CTN in 2002, with a combination of scientific and administrative leadership and excellent trial performance. The NNEN is the Lead Node on a multi-site study of prescription opioid analgesic dependence treatment, and has played a major scientific leadership role in the development and implementation of two CTN studies of patients with substance use disorder and attention deficit hyperactivity disorder. Administrative leadership is exemplified by participation by NNEN members on the 4 key CTN national committees; the NNEN is the only Node to be represented on all of these committees. NNEN members have also been elected to chair several national committees and work groups, demonstrating their excellent reputation among their CTN colleagues. Trial performance has been exemplary: the NNEN has participated in more trials and randomized more participants than any other Node entering in 2002; and has randomized more than twice as many participants in the 2005-2006 Node Trial Performance Report than the average for a CTN Node. Moreover, according to the most recent NIDA Trial Progress Report, the NNEN is the only Node (other than the 2 new Nodes entering the CTN in 2005) to meet or exceed expectations on every performance indicator of every trial the Node has entered. NNEN CTPs have adopted a number of new evidence-based practices, and have themselves disseminated information about these practices regionally, nationally, and internationally. This proposal highlights the accomplishments of the Northern New England Node in the funding period since September 2002. While the Node has made outstanding progress, the proposal also details a number of enhancements to strengthen the NNEN during the renewal period. During the next three years, the NNEN plans to continue to advance the mission of the CTN by implementing and testing state-of-the-art drug abuse treatment interventions, so that clinical programs will use the best treatments available and patients will receive the full benefit of the evolving science of addiction treatment.

这是续签“临床试验网络（CTN）：哈佛大学北部新的提案 英格兰节点，“针对RFA-DA-07-001提交的”公告，宣布了有限的竞争 国家药物滥用治疗临床试验网络（U10）。“新英格兰节点（NNEN） 汇集研究专业知识，复杂的社区治疗计划（CTP）和各种各样的 在各种环境和多个护理中接受治疗的患者。该节点的特征是 学术研究人员与基于社区的治疗提供者之间的合作伙伴关系在5个新的 英格兰国家在基于社区的治疗中设计和实施成瘾治疗研究 程序。 自2002年进入CTN以来，NNEN已表现出取得的出色进度，结合了 科学和行政领导以及出色的试验表现。 NNEN是A上的铅节点 处方阿片类镇痛依赖性治疗的多站点研究，并发挥了一项重要的科学性研究 在两项使用药物使用的患者的CTN研究开发和实施中的领导作用 障碍和注意力缺陷多动障碍。参与体现了行政领导 NNEN成员在4个关键CTN国家委员会中； NNEN是唯一在 所有这些委员会。 NNEN成员还当选为几个国家委员会主席， 工作组，证明了他们在CTN同事中的良好声誉。试验性能具有 典范：NNEN参加了更多的试验，并且比其他任何人都随机分配了更多的参与者 节点于2002年进入；并且在2005-2006节点中随机分配了两倍以上的参与者 试验性能报告比CTN节点的平均值。而且，根据最新的NIDA 试验进度报告，NNEN是唯一的节点（除了2005年进入CTN的两个新节点以外） 满足或超过节点输入每个试验的每个性能指标的期望。 nnen CTP采用了许多新的基于证据的实践，并已经传播了 有关这些实践在地区，国内和国际上的信息。 该提议突出了北部新英格兰节点在资金期间的成就 自2002年9月以来。尽管节点取得了不佳的进度，但该提案还详细介绍了一个数字 在续签期间增强NNEN的增强。在接下来的三年中，NNEN 计划通过实施和测试最先进的药物滥用来继续推进CTN的任务 治疗干预措施，以便临床计划将使用可用的最佳治疗方法，患者将 获得成瘾治疗的不断发展的科学的全部利益。